bioMérieux S.A. (BMXMF)
USD 130.17
(6.22%)
USD 130.17
(6.22%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.44 Billion EUR | 7.64% |
| 2022 | 1.34 Billion EUR | 15.67% |
| 2021 | 1.16 Billion EUR | 0.43% |
| 2020 | 1.15 Billion EUR | 7.37% |
| 2019 | 1.07 Billion EUR | 14.56% |
| 2018 | 941.2 Million EUR | 7.32% |
| 2017 | 877 Million EUR | 9.23% |
| 2016 | 802.9 Million EUR | 10.11% |
| 2015 | 729.2 Million EUR | 18.05% |
| 2014 | 617.7 Million EUR | 9.87% |
| 2013 | 562.2 Million EUR | 1.52% |
| 2012 | 553.8 Million EUR | 9.99% |
| 2011 | 503.5 Million EUR | 5.31% |
| 2010 | 478.1 Million EUR | 4.87% |
| 2009 | 455.9 Million EUR | 12.26% |
| 2008 | 406.1 Million EUR | 1.83% |
| 2007 | 398.8 Million EUR | 1.61% |
| 2006 | 392.5 Million EUR | 2.86% |
| 2005 | 381.6 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 774.5 Million EUR | 2.99% |
| 2023 Q4 | 752 Million EUR | 3.21% |
| 2023 FY | 1.44 Billion EUR | 7.64% |
| 2023 Q2 | 728.6 Million EUR | -3.33% |
| 2022 FY | 1.34 Billion EUR | 15.67% |
| 2022 Q2 | 647.6 Million EUR | 0.22% |
| 2022 Q4 | 753.7 Million EUR | 16.38% |
| 2021 Q4 | 646.2 Million EUR | 15.17% |
| 2021 FY | 1.16 Billion EUR | 0.43% |
| 2021 Q2 | 561.1 Million EUR | -6.84% |
| 2020 Q4 | 602.3 Million EUR | 3.36% |
| 2020 FY | 1.15 Billion EUR | 7.37% |
| 2020 Q2 | 582.7 Million EUR | -1.12% |
| 2019 Q2 | 528.5 Million EUR | 4.84% |
| 2019 Q4 | 589.3 Million EUR | 11.5% |
| 2019 FY | 1.07 Billion EUR | 14.56% |
| 2018 Q2 | 459.19 Million EUR | 0.31% |
| 2018 FY | 941.2 Million EUR | 7.32% |
| 2018 Q4 | 504.1 Million EUR | 9.78% |
| 2017 Q4 | 457.79 Million EUR | 2.39% |
| 2017 FY | 877 Million EUR | 9.23% |
| 2017 Q2 | 447.1 Million EUR | -0.22% |
| 2016 Q4 | 448.09 Million EUR | 18.51% |
| 2016 FY | 802.9 Million EUR | 10.11% |
| 2016 Q2 | 378.09 Million EUR | -10.68% |
| 2015 FY | 729.2 Million EUR | 18.05% |
| 2015 Q4 | 423.3 Million EUR | 13.03% |
| 2015 Q2 | 374.5 Million EUR | 8.65% |
| 2014 Q2 | 305.5 Million EUR | 0.93% |
| 2014 FY | 617.7 Million EUR | 9.87% |
| 2014 Q4 | 344.7 Million EUR | 12.83% |
| 2013 Q4 | 302.7 Million EUR | 9.04% |
| 2013 FY | 562.2 Million EUR | 1.52% |
| 2013 Q2 | 277.6 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | 553.8 Million EUR | 9.99% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | 503.5 Million EUR | 5.31% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 478.1 Million EUR | 4.87% |
| 2010 Q4 | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | 455.9 Million EUR | 12.26% |
| 2008 FY | 406.1 Million EUR | 1.83% |
| 2007 FY | 398.8 Million EUR | 1.61% |
| 2006 FY | 392.5 Million EUR | 2.86% |
| 2005 FY | 381.6 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -137898.093% |
| Arrayit Corporation | 6.19 Million USD | -23257.519% |
| Atlantic International Corp. | 5.57 Million USD | -25850.675% |
| Biocept, Inc. | 29.4 Million USD | -4823.642% |
| Bioqual, Inc. | 7.44 Million USD | -19334.078% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -187378.469% |
| DermTech, Inc. | 104.01 Million USD | -1291.722% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | -769.423% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -6298.605% |
| iMD Companies, Inc. | 151.8 Thousand USD | -953466.653% |
| IDenta Corp. | 662.97 Thousand USD | -218249.108% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -7055.002% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -3723055.269% |
| InVitro International | 661.32 Thousand USD | -218794.218% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -20294.477% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -2490951.762% |
| Medical Imaging Corp. | 1.91 Million USD | -75604.804% |
| NovelStem International Corp. | 3.53 Million USD | -40818.096% |
| Optigenex Inc. | 1.28 Million USD | -112302.737% |
| PharmChem, Inc. | 2.93 Million USD | -49285.428% |
| Proteome Sciences plc | 3.26 Million USD | -44196.206% |
| Response Genetics, Inc | 25.31 Million USD | -5617.445% |
| Rennova Health, Inc. | 7.67 Million USD | -18754.396% |
| RushNet, Inc. | 1.78 Million USD | -80802.242% |
| ScreenPro Security Inc. | 3.23 Million USD | -44594.007% |
| Stella Diagnostics Inc. | 11.42 Million USD | -12568.297% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -19613.97% |
| Todos Medical Ltd. | 14.05 Million USD | -10197.34% |